Yandrapalli, Srikanth

Global Burden of Cardiovascular Diseases and Risk Factors, 1990–2019

Roth, G. A., Mensah, G. A., Johnson, C. O., Addolorato, G., Ammirati, E., Baddour, L. M., Barengo, N. C., Beaton, A. Z., Benjamin, E. J., Benziger, C. P., et al. (2020) · Journal of the American College of Cardiology

Cardiovascular Health and Risk FactorsHealthcare Systems and Public Health

Cited by 11,449

Spatial, temporal, and demographic patterns in prevalence of smoking tobacco use and attributable disease burden in 204 countries and territories, 1990–2019: a systematic analysis from the Global Burden of Disease Study 2019

Reitsma, M. B., Kendrick, P. J., Ababneh, E., Abbafati, C., Abbasi-Kangevari, M., Abdoli, A., Abedi, A., Abhilash, E. S., Abila, D. B., Aboyans, V., et al. (2021) · The Lancet

Smoking Behavior and CessationGlobal Cancer Incidence and Screening

Cited by 1,759

Global, regional, and national progress towards Sustainable Development Goal 3.2 for neonatal and child health: All-cause and cause-specific mortality findings from the Global Burden of Disease Study 2019

Paulson, K. R., Kamath, A. M., Alam, T., Bienhoff, K., Abady, G. G., Abbas, J., Abbasi-Kangevari, M., Abbastabar, H., Abd-Allah, F., Abd-Elsalam, S. M., et al. (2021) · The Lancet

Global Maternal and Child HealthMaternal and Neonatal Healthcare

Cited by 498

Cardiovascular benefits and safety of non-insulin medications used in the treatment of type 2 diabetes mellitus

Yandrapalli, S., Jolly, G., Horblitt, A., Sanaani, A., & Aronow, W. S. (2017) · Postgraduate Medicine

Diabetes Treatment and ManagementDiabetes, Cardiovascular Risks, and Lipoproteins

Cited by 50

Use of Statins for Primary Prevention: Selection of Risk Threshold and Implications Across Race and Gender

Goyal, A., Cooper, H. A., Aronow, W. S., Nagpal, P., Yandrapalli, S., Nabors, C. C., & Frishman, W. H. (2018) · The American Journal of Medicine

Lipoproteins and Cardiovascular HealthHealth Promotion and Cardiovascular Prevention

Cited by 6